Medexus Pharmaceuticals Inc.

Toronto Stock Exchange:MDP.TO

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

Canada

Market Cap

USD 68.83 M

Share Price

USD 2.13

Avg Daily Volume

38,448

Change (1 day)

7.26%

Change (1 year)

20.62%

Change (YTD)

-11.25%

Medexus Pharmaceuticals Inc. Selling, General, and Administrative Expenses (SG&A) for the year ending March 31, 2025: USD 36.15 M

Medexus Pharmaceuticals Inc. Selling, General, and Administrative Expenses (SG&A) is USD 36.15 M for the year ending March 31, 2025, a -5.95% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.

Medexus Pharmaceuticals Inc. Selling, General, and Administrative Expenses (SG&A) for the year ending March 31, 2024 was USD 38.44 M, a -20.34% change year over year.
Medexus Pharmaceuticals Inc. Selling, General, and Administrative Expenses (SG&A) for the year ending March 31, 2023 was USD 48.25 M, a 25.02% change year over year.
Medexus Pharmaceuticals Inc. Selling, General, and Administrative Expenses (SG&A) for the year ending March 31, 2022 was USD 38.60 M, a 6.70% change year over year.
Medexus Pharmaceuticals Inc. Selling, General, and Administrative Expenses (SG&A) for the year ending March 31, 2021 was USD 36.17 M, a 75.94% change year over year.